DOI: 10.1055/s-00022861

Aktuelle Kardiologie


Haude M, Ince H, Abizaid A. et al.
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial.

Eur Heart J 2016;
37: 2701-2709

Download Bibliographical Data

Search in: